The modification in the tau protein may impair nucleic acid protection mechanisms and make hippocampus neurons more vulnerable to ROS-induced oxidative stress to their nuclear RNA and genomic DNA in AD patients. This evidence concerns the gene MAPT and Alzheimer disease.